J&J says its single-shot COVID vaccine shows strong activity against Delta

Johnson & Johnson said late Thursday that its single-shot COVID-19 vaccine generated strong, persistent activity against the Delta variant, and other highly prevalent variants.

Data showed that the durability of the immune response lasted through at least eight months, the company said.